Monica Pallis

1.6k total citations
61 papers, 1.3k citations indexed

About

Monica Pallis is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Monica Pallis has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 28 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Monica Pallis's work include Acute Myeloid Leukemia Research (38 papers), Drug Transport and Resistance Mechanisms (19 papers) and Acute Lymphoblastic Leukemia research (13 papers). Monica Pallis is often cited by papers focused on Acute Myeloid Leukemia Research (38 papers), Drug Transport and Resistance Mechanisms (19 papers) and Acute Lymphoblastic Leukemia research (13 papers). Monica Pallis collaborates with scholars based in United Kingdom, Austria and Iraq. Monica Pallis's co-authors include Nigel H. Russell, Claire Seedhouse, Julie Turzanski, Martin Grundy, Martin Grundy, N. H. Russell, Mays Jawad, Keith Wheatley, Ullas Mony and Robert K. Hills and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Monica Pallis

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Pallis United Kingdom 23 674 590 509 168 158 61 1.3k
Claire Seedhouse United Kingdom 25 1.1k 1.7× 547 0.9× 548 1.1× 158 0.9× 307 1.9× 62 1.7k
Attaya Suvannasankha United States 24 850 1.3× 875 1.5× 966 1.9× 143 0.9× 41 0.3× 76 1.7k
Margarete Zaborski Germany 20 660 1.0× 608 1.0× 306 0.6× 346 2.1× 116 0.7× 43 1.5k
Simon Bomken United Kingdom 13 376 0.6× 234 0.4× 366 0.7× 93 0.6× 202 1.3× 32 964
Kourosh Lotfi Sweden 18 400 0.6× 383 0.6× 264 0.5× 283 1.7× 141 0.9× 54 968
Annalisa Lonetti Italy 24 824 1.2× 536 0.9× 251 0.5× 280 1.7× 411 2.6× 57 1.5k
Andreas Tobler Switzerland 24 705 1.0× 332 0.6× 394 0.8× 204 1.2× 103 0.7× 49 1.2k
Fumihiko Hayakawa Japan 26 1.4k 2.0× 1.1k 1.9× 624 1.2× 430 2.6× 234 1.5× 85 2.4k
Iris Breitkreutz United States 14 879 1.3× 1.0k 1.7× 697 1.4× 132 0.8× 43 0.3× 34 1.5k

Countries citing papers authored by Monica Pallis

Since Specialization
Citations

This map shows the geographic impact of Monica Pallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Pallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Pallis more than expected).

Fields of papers citing papers by Monica Pallis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Pallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Pallis. The network helps show where Monica Pallis may publish in the future.

Co-authorship network of co-authors of Monica Pallis

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Pallis. A scholar is included among the top collaborators of Monica Pallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Pallis. Monica Pallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grundy, Martin, Claire Seedhouse, Michael D. Hall, et al.. (2018). Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling. PLoS ONE. 13(1). e0190682–e0190682. 14 indexed citations
2.
Pallis, Monica, et al.. (2016). Phenotypically Dormant and Immature Leukaemia Cells Display Increased Ribosomal Protein S6 Phosphorylation. PLoS ONE. 11(3). e0151480–e0151480. 6 indexed citations
3.
4.
Grundy, Martin, Claire Seedhouse, Nigel H. Russell, & Monica Pallis. (2011). P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B Kinase Inhibitor barasertib-hQPA. BMC Cancer. 11(1). 254–254. 16 indexed citations
5.
Grundy, Martin, et al.. (2010). The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells. Molecular Cancer Therapeutics. 9(3). 661–672. 32 indexed citations
6.
Seedhouse, Claire, et al.. (2009). FLT3‐ITD expression levels and their effect on STAT5 in AML with and without NPM mutations. British Journal of Haematology. 147(5). 653–661. 9 indexed citations
7.
Burnett, Alan K., Donald Milligan, Anthony P. Goldstone, et al.. (2009). The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial. British Journal of Haematology. 145(3). 318–332. 110 indexed citations
8.
Mony, Ullas, Mays Jawad, Claire Seedhouse, Nigel H. Russell, & Monica Pallis. (2008). Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment. Leukemia. 22(7). 1395–1401. 33 indexed citations
9.
10.
Seedhouse, Claire, Hannah Hunter, Bethan Lloyd‐Lewis, et al.. (2006). DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia. 20(12). 2130–2136. 66 indexed citations
11.
12.
Pallis, Monica & Nigel H. Russell. (2004). Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemia. Leukemia. 18(12). 1927–1930. 19 indexed citations
13.
14.
Hunter, Hannah, et al.. (2004). The expression of P‐glycoprotein in AML cells with FLT3 internal tandem duplications is associated with reduced apoptosis in response to FLT3 inhibitors. British Journal of Haematology. 127(1). 26–33. 33 indexed citations
15.
Burnett, Alan K., Robert K. Hills, A H Goldstone, et al.. (2003). Attempts to modulate chemoresistance in older patients with AML using PSC-833 - Results of the LRF AML14 trial. Blood. 102. 4 indexed citations
16.
Pallis, Monica, Julie Turzanski, Stephen E. Langabeer, & Nigel H. Russell. (1999). Reproducible Flow Cytometric Methodology for Measuring Multidrug Resistance in Leukaemic Blasts. Advances in experimental medicine and biology. 457. 77–88. 13 indexed citations
17.
18.
Pallis, Monica. (1998). Functional multidrug resistance in acute myeloblastic leukaemia: a standardized flow cytometric assay for intracellular daunorubicin accumulation. British Journal of Haematology. 100(1). 194–194. 6 indexed citations
19.
Pallis, Monica, R. A. Robins, & Roy Powell. (1996). Peripheral Blood Lymphocyte Adhesion Molecule Deployment in the Immune Response. Scandinavian Journal of Immunology. 43(3). 304–313. 3 indexed citations
20.
Pallis, Monica, A. Robins, & Roy Powell. (1993). Quantitative Analysis of Lymphocyte CD1 la using Standardized Flow Cytometry. Scandinavian Journal of Immunology. 38(6). 559–564. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Seedhouse Breakdown of academic impact, for papers by Attaya Suvannasankha Breakdown of academic impact, for papers by Margarete Zaborski Breakdown of academic impact, for papers by Simon Bomken Breakdown of academic impact, for papers by Kourosh Lotfi Breakdown of academic impact, for papers by Annalisa Lonetti Breakdown of academic impact, for papers by Andreas Tobler Breakdown of academic impact, for papers by Fumihiko Hayakawa Breakdown of academic impact, for papers by Iris Breitkreutz
Rankless by CCL
2026